4-Methylphenmetrazine

4-Methylphenmetrazine

4-Methylphenmetrazine

Stimulant designer drug

4-Methylphenmetrazine (mephenmetrazine, 4-MPM, PAL-747) is a recreational designer drug with stimulant effects. It is a substituted phenylmorpholine derivative, closely related to better known drugs such as phenmetrazine and 3-fluorophenmetrazine. It was first identified in Slovenia in 2015,[1][2] and has been shown to act as a monoamine releaser with some preference for serotonin release.[3][4]

Quick Facts Identifiers, CAS Number ...

See also

References

  1. [1]
    "Analytical Report. 4-MPH (C12H17NO) 3-methyl-2(p-tolyl)morpholine" (PDF). National Forensic Laboratory. Slovenia. 14 October 2015.
  2. [2]
    "Europol 2015 Annual Report on the implementation of Council Decision 2005/387/JHA" (PDF). The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) & Europol.
  3. [3]
    US 20130203752, Blough BE, Rothman R, Landavazo A, Page KM, Decker AM, "Phenylmorpholines and analogues thereof", published 8 August 2013, issued 11 April 2017, assigned to National Institutes of Health, U.S. Department of Health and Human Services
  4. [4]
    McLaughlin G, Baumann MH, Kavanagh PV, Morris N, Power JD, Dowling G, et al. (September 2018). "Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers". Drug Testing and Analysis. 10 (9): 1404–1416. doi:10.1002/dta.2396. PMC 7316143. PMID 29673128.
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article 4-Methylphenmetrazine, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.